These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7666706)

  • 21. Stability of patients' preferences for chemotherapy: the impact of experience.
    Jansen SJ; Kievit J; Nooij MA; Stiggelbout AM
    Med Decis Making; 2001; 21(4):295-306. PubMed ID: 11475386
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Associations between health status and utilities implications for policy.
    Lenert LA; Treadwell JR; Schwartz CE
    Med Care; 1999 May; 37(5):479-89. PubMed ID: 10335750
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intensity of chemotherapy-induced emesis and overall survival as determinants of a global utility score.
    Grunberg SM; Srivastava A; Grunberg KJ; Weeks J
    Support Care Cancer; 2002 Nov; 10(8):624-9. PubMed ID: 12436221
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Eliciting Health State Utilities Using Paired-Gamble Methods: The Role of the Starting Point.
    Rodríguez-Míguez E; Pinto-Prades JL; Mosquera-Nogueira J
    Value Health; 2019 Apr; 22(4):446-452. PubMed ID: 30975396
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiattribute utility function for a comprehensive health status classification system. Health Utilities Index Mark 2.
    Torrance GW; Feeny DH; Furlong WJ; Barr RD; Zhang Y; Wang Q
    Med Care; 1996 Jul; 34(7):702-22. PubMed ID: 8676608
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Invariance and inconsistency in utility ratings.
    Bravata DM; Nelson LM; Garber AM; Goldstein MK
    Med Decis Making; 2005; 25(2):158-67. PubMed ID: 15800300
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patient-based utilities for bipolar disorder-related health states.
    Revicki DA; Hanlon J; Martin S; Gyulai L; Nassir Ghaemi S; Lynch F; Mannix S; Kleinman L
    J Affect Disord; 2005 Aug; 87(2-3):203-10. PubMed ID: 16005983
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Validity of standard gamble estimated quality of life in acute venous thrombosis.
    Hogg K; Shaw J; Coyle D; Fallah P; Carrier M; Wells P
    Thromb Res; 2014 Oct; 134(4):819-25. PubMed ID: 25174282
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An experimental test of a theoretical foundation for rating-scale valuations.
    Bleichrodt H; Johannesson M
    Med Decis Making; 1997; 17(2):208-16. PubMed ID: 9107617
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Willingness to accept risk in the treatment of rheumatic disease.
    O'Brien BJ; Elswood J; Calin A
    J Epidemiol Community Health; 1990 Sep; 44(3):249-52. PubMed ID: 2273365
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Variation in patient utilities for outcomes of the management of chronic stable angina. Implications for clinical practice guidelines. Ischemic Heart Disease Patient Outcomes Research Team.
    Nease RF; Kneeland T; O'Connor GT; Sumner W; Lumpkins C; Shaw L; Pryor D; Sox HC
    JAMA; 1995 Apr; 273(15):1185-90. PubMed ID: 7707625
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quality of life, health-state utilities and willingness to pay in patients with psoriasis and atopic eczema.
    Lundberg L; Johannesson M; Silverdahl M; Hermansson C; Lindberg M
    Br J Dermatol; 1999 Dec; 141(6):1067-75. PubMed ID: 10606854
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lack of congruence in the ratings of patients' health status by patients and their physicians.
    Suarez-Almazor ME; Conner-Spady B; Kendall CJ; Russell AS; Skeith K
    Med Decis Making; 2001; 21(2):113-21. PubMed ID: 11310944
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Measurement of health state utilities for economic appraisal.
    Torrance GW
    J Health Econ; 1986 Mar; 5(1):1-30. PubMed ID: 10311607
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trends in the measurement of health utilities in published cost-utility analyses.
    Brauer CA; Rosen AB; Greenberg D; Neumann PJ
    Value Health; 2006; 9(4):213-8. PubMed ID: 16903990
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patient utilities for advanced cancer: effect of current health on values.
    Wittenberg E; Winer EP; Weeks JC
    Med Care; 2005 Feb; 43(2):173-81. PubMed ID: 15655431
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiattribute health utility scoring for the computerized adaptive measure CAT-5D-QOL was developed and validated.
    Kopec JA; Sayre EC; Rogers P; Davis AM; Badley EM; Anis AH; Abrahamowicz M; Russell L; Rahman MM; Esdaile JM
    J Clin Epidemiol; 2015 Oct; 68(10):1213-20.e1-6. PubMed ID: 25990544
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Public preferences for health states with schizophrenia and a mapping function to estimate utilities from positive and negative symptom scale scores.
    Lenert LA; Sturley AP; Rapaport MH; Chavez S; Mohr PE; Rupnow M
    Schizophr Res; 2004 Nov; 71(1):155-65. PubMed ID: 15374583
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of including (versus excluding) fates worse than death on utility measurement.
    Franic DM; Pathak DS
    Int J Technol Assess Health Care; 2003; 19(2):347-61. PubMed ID: 12862192
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The relationship between descriptive and valuational quality-of-life measures in patients with intermittent claudication.
    Bosch JL; Hunink MG
    Med Decis Making; 1996; 16(3):217-25. PubMed ID: 8818119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.